Search

everythinglearnresearchcommunity

for

Search:↓

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Women, younger age, and low BMI increase the risk of long COVID symptoms.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

More research is needed to understand sex and racial differences in long COVID.

COVID-19 may cause hair loss by affecting hair follicles.

COVID-19 can cause temporary hair loss.

Some people lose a lot of hair after having COVID-19.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

COVID-19 vaccination may lower vitamin D levels and cause hair loss.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Genetic differences affect COVID-19 severity and treatment development.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Pexidartinib often causes liver issues and fatigue, especially in women.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.